1. Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia;
2. Lymphocyte Signalling and Development Institute Strategic Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom;
3. Laboratory for Molecular Immunomodulation, Department of Biochemistry and Molecular Biology, and Center for Inflammatory Diseases, Monash University, Melbourne, Victoria 3800, Australia;
4. School of Immunity and Infection, University of Birmingham, Birmingham B15 2TT, United Kingdom